135 related articles for article (PubMed ID: 12969697)
1. Widespread increases of cortical serotonin type 2A receptor availability after hormone therapy in euthymic postmenopausal women.
Moses-Kolko EL; Berga SL; Greer PJ; Smith G; Cidis Meltzer C; Drevets WC
Fertil Steril; 2003 Sep; 80(3):554-9. PubMed ID: 12969697
[TBL] [Abstract][Full Text] [Related]
2. Effects of estradiol and progesterone administration on human serotonin 2A receptor binding: a PET study.
Moses EL; Drevets WC; Smith G; Mathis CA; Kalro BN; Butters MA; Leondires MP; Greer PJ; Lopresti B; Loucks TL; Berga SL
Biol Psychiatry; 2000 Oct; 48(8):854-60. PubMed ID: 11063980
[TBL] [Abstract][Full Text] [Related]
3. Increase in prefrontal cortex serotonin 2A receptors following estrogen treatment in postmenopausal women.
Kugaya A; Epperson CN; Zoghbi S; van Dyck CH; Hou Y; Fujita M; Staley JK; Garg PK; Seibyl JP; Innis RB
Am J Psychiatry; 2003 Aug; 160(8):1522-4. PubMed ID: 12900319
[TBL] [Abstract][Full Text] [Related]
4. Visualisation of loss of 5-HT2A receptors with age in healthy volunteers using [18F]altanserin and positron emission tomographic imaging.
Rosier A; Dupont P; Peuskens J; Bormans G; Vandenberghe R; Maes M; de Groot T; Schiepers C; Verbruggen A; Mortelmans L
Psychiatry Res; 1996 Nov; 68(1):11-22. PubMed ID: 9027929
[TBL] [Abstract][Full Text] [Related]
5. Cortical and subcortical 5-HT2A receptor binding in neuroleptic-naive first-episode schizophrenic patients.
Erritzoe D; Rasmussen H; Kristiansen KT; Frokjaer VG; Haugbol S; Pinborg L; Baaré W; Svarer C; Madsen J; Lublin H; Knudsen GM; Glenthoj BY
Neuropsychopharmacology; 2008 Sep; 33(10):2435-41. PubMed ID: 18288096
[TBL] [Abstract][Full Text] [Related]
6. Direct comparison of [(18) F]MH.MZ and [(18) F] altanserin for 5-HT2A receptor imaging with PET.
Hansen HD; Ettrup A; Herth MM; Dyssegaard A; Ratner C; Gillings N; Knudsen GM
Synapse; 2013 Jun; 67(6):328-37. PubMed ID: 23390031
[TBL] [Abstract][Full Text] [Related]
7. Endogenous plasma estradiol in healthy men is positively correlated with cerebral cortical serotonin 2A receptor binding.
Frokjaer VG; Erritzoe D; Juul A; Nielsen FA; Holst K; Svarer C; Madsen J; Paulson OB; Knudsen GM
Psychoneuroendocrinology; 2010 Oct; 35(9):1311-20. PubMed ID: 20356681
[TBL] [Abstract][Full Text] [Related]
8. Analyses of [(18)F]altanserin bolus injection PET data. II: consideration of radiolabeled metabolites in humans.
Price JC; Lopresti BJ; Meltzer CC; Smith GS; Mason NS; Huang Y; Holt DP; Gunn RN; Mathis CA
Synapse; 2001 Jul; 41(1):11-21. PubMed ID: 11354009
[TBL] [Abstract][Full Text] [Related]
9. Test-retest variability of serotonin 5-HT2A receptor binding measured with positron emission tomography and [18F]altanserin in the human brain.
Smith GS; Price JC; Lopresti BJ; Huang Y; Simpson N; Holt D; Mason NS; Meltzer CC; Sweet RA; Nichols T; Sashin D; Mathis CA
Synapse; 1998 Dec; 30(4):380-92. PubMed ID: 9826230
[TBL] [Abstract][Full Text] [Related]
10. Effects of hormone replacement therapy on cerebral serotonin-1A receptor binding in postmenopausal women examined with [carbonyl-¹¹C]WAY-100635.
Kranz GS; Rami-Mark C; Kaufmann U; Baldinger P; Hahn A; Höflich A; Savli M; Stein P; Wadsak W; Mitterhauser M; Winkler D; Lanzenberger R; Kasper S
Psychoneuroendocrinology; 2014 Jul; 45():1-10. PubMed ID: 24845171
[TBL] [Abstract][Full Text] [Related]
11. PET imaging of serotonin type 2A receptors in late-life neuropsychiatric disorders.
Meltzer CC; Price JC; Mathis CA; Greer PJ; Cantwell MN; Houck PR; Mulsant BH; Ben-Eliezer D; Lopresti B; DeKosky ST; Reynolds CF
Am J Psychiatry; 1999 Dec; 156(12):1871-8. PubMed ID: 10588399
[TBL] [Abstract][Full Text] [Related]
12. Evidence for chronically altered serotonin function in the cerebral cortex of female 3,4-methylenedioxymethamphetamine polydrug users.
Di Iorio CR; Watkins TJ; Dietrich MS; Cao A; Blackford JU; Rogers B; Ansari MS; Baldwin RM; Li R; Kessler RM; Salomon RM; Benningfield M; Cowan RL
Arch Gen Psychiatry; 2012 Apr; 69(4):399-409. PubMed ID: 22147810
[TBL] [Abstract][Full Text] [Related]
13. 5-HT2A receptor density is decreased in the at-risk mental state.
Hurlemann R; Matusch A; Kuhn KU; Berning J; Elmenhorst D; Winz O; Kolsch H; Zilles K; Wagner M; Maier W; Bauer A
Psychopharmacology (Berl); 2008 Jan; 195(4):579-90. PubMed ID: 17899021
[TBL] [Abstract][Full Text] [Related]
14. Altered serotonin 2A receptor activity in women who have recovered from bulimia nervosa.
Kaye WH; Frank GK; Meltzer CC; Price JC; McConaha CW; Crossan PJ; Klump KL; Rhodes L
Am J Psychiatry; 2001 Jul; 158(7):1152-5. PubMed ID: 11431241
[TBL] [Abstract][Full Text] [Related]
15. [¹⁸F]Altanserin and small animal PET: impact of multidrug efflux transporters on ligand brain uptake and subsequent quantification of 5-HT₂A receptor densities in the rat brain.
Kroll T; Elmenhorst D; Matusch A; Celik AA; Wedekind F; Weisshaupt A; Beer S; Bauer A
Nucl Med Biol; 2014 Jan; 41(1):1-9. PubMed ID: 24120220
[TBL] [Abstract][Full Text] [Related]
16. Comparison of [(18)F]altanserin and [(18)F]deuteroaltanserin for PET imaging of serotonin(2A) receptors in baboon brain: pharmacological studies.
Staley JK; Van Dyck CH; Tan PZ; Al Tikriti M; Ramsby Q; Klump H; Ng C; Garg P; Soufer R; Baldwin RM; Innis RB
Nucl Med Biol; 2001 Apr; 28(3):271-9. PubMed ID: 11323237
[TBL] [Abstract][Full Text] [Related]
17. Serotonin 2A receptor agonist binding in the human brain with [(11)C]Cimbi-36: Test-retest reproducibility and head-to-head comparison with the antagonist [(18)F]altanserin.
Ettrup A; Svarer C; McMahon B; da Cunha-Bang S; Lehel S; Møller K; Dyssegaard A; Ganz M; Beliveau V; Jørgensen LM; Gillings N; Knudsen GM
Neuroimage; 2016 Apr; 130():167-174. PubMed ID: 26876490
[TBL] [Abstract][Full Text] [Related]
18. Estradiol effects on the postmenopausal brain.
Moses-Kolko EL; Meltzer CC; Greer P; Butters M; Berga SL; Smith G; Drevets WC
Am J Psychiatry; 2004 Nov; 161(11):2136; author reply 2136. PubMed ID: 15514428
[No Abstract] [Full Text] [Related]
19. Analyses of [(18)F] altanserin bolus injection PET data. I: consideration of radiolabeled metabolites in baboons.
Price JC; Lopresti BJ; Mason NS; Holt DP; Huang Y; Mathis CA
Synapse; 2001 Jul; 41(1):1-10. PubMed ID: 11354008
[TBL] [Abstract][Full Text] [Related]
20. Equilibrium modeling of 5-HT(2A) receptors with [18F]deuteroaltanserin and PET: feasibility of a constant infusion paradigm.
van Dyck CH; Soares JC; Tan PZ; Staley JK; Baldwin RM; Amici LA; Fu X; Garg PK; Seibyl JP; Charney DS; Innis RB
Nucl Med Biol; 2000 Nov; 27(8):715-22. PubMed ID: 11150702
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
